Search for Clinical Trial Results
Angiomyolipoma - 12 Studies Found
| Status | Study |
| Completed |
Study Name: Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis Condition: Angiomyolipoma Date: 2010-10-06 Interventions: Drug: Sirolimus plasma levels between 4 and 8 Other |
| Recruiting |
Study Name: Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus Condition: Sporadic Angiomyolipomas (AMLs) Date: 2015-08-20 Interventions: Drug: Everolimus 10 mg tablets |
| Recruiting |
Study Name: Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers Condition:
Date: 2014-04-01 Interventions: Drug: Propranolol |
| Recruiting |
Study Name: Sirolimus in Treating Patients With Angiomyolipoma of the Kidney Condition: Nonmalignant Neoplasm Date: 2005-08-02 Interventions: Drug: sirolimus |
| Recruiting |
Study Name: Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma Condition:
Date: 2008-11-10 Interventions:
|
| Completed |
Study Name: RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM Condition:
Date: 2007-04-06 Interventions: Drug: RAD001 5 and 10 mg/day or 30, 50, 70mg/week |
| Completed |
Study Name: Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM) Condition:
Date: 2008-11-17 Interventions: Drug: everolimus (RAD001) Subjects will resume the dosing regimen that they were receiving at the comple |
| Completed |
Study Name: Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM Condition:
Date: 2007-04-06 Interventions: Drug: Rapamycin, sirolimus |